EUVIMEDEUVIMED entdecken
Crossref

In Brief: Alternatives to Mifepristone for Medication Abortion

The Medical Letter on Drugs and Therapeutics · 2023

DOI: 10.58347/tml.2023.1679d ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Medical Letter on Drugs and Therapeutics, 2023. Hauptthemen laut MEDLINE: Abortion, Induced, Abortifacient Agents, Steroidal, Misoprostol, Abortifacient Agents, Nonsteroidal.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The possibility that use of mifepristone (Mifeprex, and generics) may be restricted has led to questions about alternatives for medication abortion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Abortion, InducedAbortifacient Agents, SteroidalMisoprostolAbortifacient Agents, NonsteroidalPregnancyFemaleHumansMifepristone

Stichwörter der Autor:innen

CytotecMifeprexadverse effectsdosageefficacyletrozolemethotrexatemifepristonemisoprostolsafety

Substanzen

MifepristoneAbortifacient Agents, SteroidalMisoprostolAbortifacient Agents, Nonsteroidal

Zitieren

APA

(2023). In Brief: Alternatives to Mifepristone for Medication Abortion. The Medical Letter on Drugs and Therapeutics. https://doi.org/10.58347/tml.2023.1679d

Vancouver

In Brief: Alternatives to Mifepristone for Medication Abortion. The Medical Letter on Drugs and Therapeutics. 2023. doi:10.58347/tml.2023.1679d

BibTeX
@article{euvimed2023,
  title = {In Brief: Alternatives to Mifepristone for Medication Abortion},
  journal = {The Medical Letter on Drugs and Therapeutics},
  year = {2023},
  doi = {10.58347/tml.2023.1679d}
}
Kostenlos starten →